« hESC Research Gets Stay from Federal Appeals Court | Main | BMS Hits Early ZymoGenetics Jackpot »

09/29/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b013487d31fde970c

Listed below are links to weblogs that reference "Stonewall" Termeer Ready to Sashay if Sanofi Price is Right:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

In a somewhat contrary view, Seeking Alpha writes that Sanofi is under greater pressure to do th eGenzyme deal faster since its Toxotere lost in court in attempt to block generic competition. Taxotere represents 8% of Sanofi revenue in 2009.
http://seekingalpha.com/article/228138-court-ruling-increases-pressure-on-sanofi-to-buy-genzyme

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada